246 related articles for article (PubMed ID: 2587939)
1. The outcome of Pneumocystis carinii pneumonia in Danish patients with AIDS.
Pedersen C; Lundgren JD; Nielsen T; Andersen WH
Scand J Infect Dis; 1989; 21(4):375-80. PubMed ID: 2587939
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
3. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
4. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ.
Gluckstein D; Ruskin J
Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis carinii pneumonia and its treatment in patients with AIDS.
Gazzard BG
J Antimicrob Chemother; 1989 Jan; 23 Suppl A():67-75. PubMed ID: 2654117
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial.
Klein NC; Duncanson FP; Lenox TH; Forszpaniak C; Sherer CB; Quentzel H; Nunez M; Suarez M; Kawwaff O; Pitta-Alvarez A
AIDS; 1992 Mar; 6(3):301-5. PubMed ID: 1567574
[TBL] [Abstract][Full Text] [Related]
7. Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome.
Wofsy CB
Rev Infect Dis; 1987; 9 Suppl 2():S184-94. PubMed ID: 3554457
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii pneumonia in Stockholm, Sweden: treatment, outcome, one-year-follow-up and pyrimethamine prophylaxis.
Lidman C; Ortqvist A; Lundbergh P; Julander I; Bergdahl S
Scand J Infect Dis; 1989; 21(4):381-7. PubMed ID: 2587940
[TBL] [Abstract][Full Text] [Related]
10. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease.
Ruskin J; LaRiviere M
Lancet; 1991 Feb; 337(8739):468-71. PubMed ID: 1671479
[TBL] [Abstract][Full Text] [Related]
11. Three cases of acquired immunodeficiency syndrome complicated with toxic epidermal necrolysis.
Kimura S; Oka S; Mohri H; Mitamura K; Shimada K
Jpn J Med; 1991; 30(6):553-8. PubMed ID: 1798215
[TBL] [Abstract][Full Text] [Related]
12. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
May T; Beuscart C; Reynes J; Marchou B; Leclercq P; Borsa Lebas F; Saba J; Micoud M; Mouton Y; Canton P
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):457-62. PubMed ID: 8158539
[TBL] [Abstract][Full Text] [Related]
15. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
[TBL] [Abstract][Full Text] [Related]
16. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia.
Castellano AR; Nettleman MD
JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus.
MMWR Recomm Rep; 1992 Apr; 41(RR-4):1-11. PubMed ID: 1348843
[TBL] [Abstract][Full Text] [Related]
18. Decisions in P. carinii pneumonia.
Frank I; MacGregor RR
Hosp Pract (Off Ed); 1990 Apr; 25(4A):8, 13-4. PubMed ID: 2109757
[No Abstract] [Full Text] [Related]
19. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Martin MA; Cox PH; Beck K; Styer CM; Beall GN
Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
[TBL] [Abstract][Full Text] [Related]
20. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]